Waldron Private Wealth’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-288	Closed	-$205K	–	399
2024 Q4	$205K	Sell	288 -78	-21%	-$65.5K	0.01%	399
2024 Q3	$385K	Buy	366 +4	+1%	+$4.45K	0.02%	289
2024 Q2	$380K	Sell	362 -7	-2%	-$6.79K	0.02%	275
2024 Q1	$355K	Buy	369 +10	+3%	+$9.51K	0.02%	283
2023 Q4	$315K	Buy	359 +61	+20%	+$50.2K	0.02%	300
2023 Q3	$245K	Buy	298 +4	+1%	+$3.14K	0.01%	320
2023 Q2	$211K	Sell	294 -25	-8%	-$19.3K	0.01%	350
2023 Q1	$262K	Buy	+319	New	+$241K	0.01%	345
2017 Q2	–	Sell	-652	Closed	-$240K	–	189
2017 Q1	$240K	Sell	652 -222	-25%	-$82.3K	0.06%	186
2016 Q4	$320K	Buy	874 +18	+2%	+$6.84K	0.11%	86
2016 Q3	$344K	Buy	856 +18	+2%	+$7.22K	0.12%	80
2016 Q2	$292K	Sell	838 -8	-0.9%	-$3.08K	0.11%	105
2016 Q1	$304K	Buy	846 +11	+1%	+$4.53K	0.11%	90
2015 Q4	$453K	Buy	835 +13	+2%	+$7.04K	0.17%	71
2015 Q3	$382K	Buy	822 +57	+7%	+$30.6K	0.16%	60
2015 Q2	$390K	Buy	765 +47	+7%	+$22.9K	0.15%	55
2015 Q1	$324K	Buy	718 +213	+42%	+$90.3K	0.13%	62
2014 Q4	$207K	Buy	+505	New	+$199K	0.09%	119